International consensus recommendations for the adult pathway of controlled donation after circulatory determination of death (cDCDD)

Helen Opdam, Australia

National Medical Director
Austtralian Organ and Tissue Authority

Biography

Associate Professor Helen Opdam is the National Medical Director of the Australian Organ and Tissue Authority. She is a Senior Intensive Care Specialist at the Austin Hospital in Melbourne and Director of Warringal Private Hospital Intensive Care Unit. Helen is President of the International Society for Organ Donation Professionals (ISODP), currently serving a 2-year term (2023-2025).

Abstract

International consensus recommendations for the adult pathway of controlled donation after circulatory determination of death (cDCDD)

Helen Opdam1,2, Alicia Perez-Blanco3, Dale Gardiner4, Richard D Hasz5, Matthieu Le Dorze6,7, Nichon Jansen8, Alberto Sandiumenge9, Giuliano Testa10, Shih-Ning Then11, Marinella Zanierato12, Umberto Cillo13, Dominique E Martin14.

1Australian Organ and Tissue Authority, Canberra, Australia; 2Intensive Care, Austin Health, Melbourne, Australia; 3Organización Nacional de Trasplantes, Madrid, Spain; 4Organ and Tissue Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom; 5Gift of Life Donor Program, Philadelphia, United States; 6Department of Anesthesia and Critical Care Medicine, Lariboisière Hospital, Paris, France; 7Université Paris-Saclay, Paris, France; 8Dutch Transplant Foundation, Leiden, Netherlands; 9Dept of Donor & Transplant, Transplant Coordn, Clin Research/Epidemiology In Pneumonia & Sepsis, Vall d´Hebrón University Hospital, Barcelona, Spain; 10Department of Surgery, Baylor University Medical Center, Dallas, TX, United States; 11Faculty of Business & Law, Queensland University of Technology, Brisbane, Australia; 12Department of Anesthesia and Critical Care, Molinette Hospital, Turin, Italy; 13Dept of Surg, Oncological & Gastroenterological Sciences, General & Hepato-Pancreato-Biliary Surgery, Padua University Hospital, Padua, Italy; 14School of Medicine, Deakin University, Geelong, Australia

Introduction: cDCDD has immense potential to expand deceased organ donation and transplantation worldwide.  Barriers to its uptake include a lack of consensus on ethical, legal and clinical practices. In 2024, the European Society of Organ Transplantation (ESOT) led an international project to address uncertainties in cDCDD and make recommendations for adult and paediatric donor management, use of NRP, and the unified concept of death. We report here the work of the subgroup dedicated to adult cDCDD.
Methods: A modified Delphi process was conducted by independent company Adelphi Targis comprising two survey rounds administered online in English. An international multidisciplinary committee of experts in deceased donation developed the questionnaire and identified expert panelists to participate in the study. Panelists indicated their level of agreement with statements relating to patient suitability for cDCDD, family communication, end-of-life care and decision-making about cDCDD, and use ante mortem interventions. The questionnaire was revised following review of the first survey round results at a meeting in Bucharest, Romania on 12-10-2024.
Results: 37 international expert panelists from 15 countries completed the survey; 65% were male. Consensus was reached on 33 major recommendations. These highlighted the importance of:
- mechanisms for the routine identification of patients potentially suitable for cDCDD;
- maintenance of life-support measures until there has ocurred evaluation of suitability for cDCDD and, where appropriate, discussion with family to offer donation;
- the cDCDD suitability evaluation being multidisciplinary and involving donation personnel;
family communication about cDCDD being initiated by trained donation professionals and only after family understand that death will occur;
- the approach to end-of-life care being consistent with routine end-of-life care in the absence of cDCDD, including the provision of sedatives and analgesics for comfort care, and family being offered the option of being present during withdrawal of life sustaining measures until death; and,
- the use of ante-mortem interventions being considered if their potential benefits outweigh their potential burdens or risks.
There was also consensus that when cDCDD programs are introduced, opportunities for donation after neurological determination of death (DNDD) should be prioritised and that careful introduction of cDCDD programs may result in additional DNDD, as a proportion of patients who are evaluated as potential donors via cDCDD will proceed to DNDD.
Conclusion: This international initiative achieved consensus addressing ethical, legal and clinical practice uncertainties or controversies with recommendations to optimise opportunities for successful recovery and transplantation of organs via cDCDD.

The European Society for Organ Transplantation (ESOT) provided funding and support for this work..

References:

[1] Organ donation
[2] Donation after circulatory determination of death
[3] Donation after circulatory death
[4] Deceased donation
[5] DCD

Email: info@2025.isodp.org
514-874-1717